| Code | Description | Claims | Beneficiaries | Total Paid |
| 90999 |
|
82,269 |
6,827 |
$4.45M |
| A4657 |
Syringe, with or without needle, each |
8,701 |
4,717 |
$2K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
57,629 |
3,566 |
$2K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
31,092 |
2,654 |
$817.89 |
| J1756 |
Injection, iron sucrose, 1 mg |
12,823 |
3,506 |
$305.79 |
| G0008 |
Administration of influenza virus vaccine |
208 |
194 |
$154.85 |
| 82607 |
|
151 |
147 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
1,675 |
1,268 |
$0.00 |
| 83550 |
|
1,788 |
1,716 |
$0.00 |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
1,767 |
579 |
$0.00 |
| 82728 |
|
2,337 |
2,248 |
$0.00 |
| 82306 |
|
157 |
153 |
$0.00 |
| 90674 |
|
43 |
43 |
$0.00 |
| 82746 |
|
83 |
81 |
$0.00 |
| 0012A |
|
16 |
16 |
$0.00 |
| 85048 |
|
3,452 |
3,233 |
$0.00 |
| 83540 |
|
2,464 |
2,340 |
$0.00 |
| 85041 |
|
3,464 |
3,244 |
$0.00 |
| 83970 |
|
3,203 |
2,923 |
$0.00 |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
1,077 |
605 |
$0.00 |
| 82108 |
|
1,106 |
1,070 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
467 |
38 |
$0.00 |
| 85045 |
|
18 |
15 |
$0.00 |
| 90662 |
|
38 |
38 |
$0.00 |